RHYTHM PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Rhythm Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Rhythm Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $3.7M, a 273% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.7M +$2.71M +273% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $670K -$418K -38.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $781K -$401K -33.9% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $888K -$385K -30.2% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $990K -$369K -27.2% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $1.09M -$354K -24.5% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $1.18M -$340K -22.3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.27M -$325K -20.3% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.36M -$312K -18.7% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $1.44M -$299K -17.2% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $1.52M -$285K -15.8% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $1.6M -$273K -14.6% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $1.67M -$261K -13.5% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $1.74M -$248K -12.5% Mar 31, 2021 10-Q 2021-05-03
Q4 2020 $1.81M -$238K -11.6% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.87M -$226K -10.8% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $1.93M -$1.15M -37.4% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 $1.99M -$1.19M -37.3% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $2.05M -$1.22M -37.4% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.1M Sep 30, 2019 10-Q 2019-11-01
Q2 2019 $3.09M Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $3.17M Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $3.27M Dec 31, 2018 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.